Recovery Is Real, but the Growth Gamble Just Got Riskier
Collections rallied sharply and disbursements hit a record, yet profit grew just 1.9% YoY — and AUM is tracking at a pace that would miss the 20% FY27 guidance by 400 basis points. The operational story is not the earnings story.
₹271 Cr
+1.9% YoY
6%
up from 5% hist. / +20–21% YoY
4% QoQ
~16% annualized vs 20% FY27 target
97.9%
Current book 83.3% (+61 bps QoQ)
The paradox of Q1 is crisp: Five-Star achieved its highest-ever quarterly disbursement of ₹1,496 Cr, collections surged to 97.9% efficiency with the current book improving 61 basis points quarter-on-quarter, and credit cost fell to 1.85% — all genuine wins that validate the business recovery narrative. And yet reported profit grew only 1.9% YoY, revenue rose just 5.4%, and the AUM growth rate sits at a 4% QoQ pace that, if sustained, would translate to roughly 16% annualized expansion — a full 400 basis points short of the company's stated 20% FY27 guidance. That gap is the story.
What management got right — the operational wins
Collections rally genuine: Current book 83.3%, up 61 bps QoQ; 30+ bucket down to 12.38% from 12.69%; efficiency 97.9% stable despite seasonal Q1 softness
Disbursements reset higher: ₹1,496 Cr in Q1 (+23% QoQ, +16% YoY); June run-rate ₹670 Cr suggests ₹600–650 Cr normalized monthly — up from ₹400s-era baseline
Credit cost trending right: Q1 at 1.85%, within 1.7–1.9% FY27 guidance and on track toward management's 1.7% target as collections strengthen
Scale milestone hit: 500k active customers, 856 branches, 12 branch additions Q1 — network infrastructure in place for growth acceleration
Where the profit growth went missing
Operating expense inflation is eating the gains. Opex stood at 6% of AUM in Q1 — up sharply from the historical 5% baseline — and grew 20–21% year-on-year in absolute terms. This offset the benefit of a 20–21% YoY salary and incentive restructuring tied to the business/collections split, which was supposed to unlock productivity. Credit cost improvement alone should have lifted net interest margin; instead, NIM sat flat, and net profit growth lagged revenue growth. The company has explicitly pushed operating leverage to FY28, guiding for opex of 5.75–6% in FY27 and a steady-state 5.25–5.5% thereafter. In other words: near-term margin compression by design, not accident.
Management's claims vs. what holds up
20% AUM growth FY27 'very comfortably' achievable
Q1 pace ₹13,722 Cr AUM, +4% QoQ = ~16% annualized if sustained. June disburse ₹670 Cr run-rate consistent with historical seasonal pattern, not evidence of step-change.
Overstated
Record disbursements ₹1,496 Cr validate momentum
Supported. ₹1,496 Cr Q1 is highest quarterly ever, +23% QoQ, +16% YoY. But repayments remain elevated; net AUM growth only 4% QoQ.
Supported (partial context)
ROA 8.25–8.5% FY27 target
Q1 ROA 8.11%, below guidance floor. Opex at 6% (up from 5%) neutralizes credit cost gains. No path to guidance in FY27 under current opex trajectory.
Contradicted
Credit cost 1.7–1.9% FY27, trend toward 1.7%
Q1 at 1.85%, supported. Collections strength and slippage stabilization back the guidance.
Supported
Collections robust, no portfolio stress
Supported. Current book 83.3% (+61 bps QoQ), 30+ at 12.38% (down 31 bps), efficiency 97.9% despite seasonal Q1 softness. Slippages flat at 0.70%. Genuine improvement.
Supported
The AUM growth problem — and why it matters
A 4% QoQ AUM expansion is a red flag when guidance is 20% annualized. Management's confidence rests on the assumption that disbursements will sustain at ₹1,500 Cr per quarter, with a 10% seasonal uplift in Q3–Q4, yielding ₹6,500–6,800 Cr annual disbursements and hitting 20% growth. That math is mathematically possible. But it requires repayments to normalize — a reversal of the elevated repayment rates the company has been experiencing as collections efficiency improves. On the call, management acknowledged that repayment rates are currently running 30%, above the normalized 27–28% target. Until those rates drift down, even record disbursements will not compound to 20% AUM growth. Q1's 4% QoQ pace was with ₹1,496 Cr in disbursements. If the math worked as management claims, Q1 should have shown higher AUM growth, not lower.
The street's take — and a shift in ownership
The market's initial reaction was recovery-positive: the stock popped 0.94% on day 1 post-announcement (with 34.7% delivery), accelerated to +6.23% by day 3, and settled +2.38% by day 5. The move held, suggesting genuine institutional validation of the operational turnaround. However, ownership data tell a different story. FII holding shrank 447 basis points to 48.47% in Q4 FY26 from 52.94% in Q3, while domestic institutions added 285 basis points to 17.58%. That is, foreign money is trimming into the recovery narrative, and domestic dii is the buyer. On valuation: the stock trades at ₹547.95, down 17.7% from its all-time high of ₹666 but up 62% off its 52-week low of ₹338.25. It sits above its 50-day and 200-day simple moving averages (₹501.85 and ₹498, respectively) but just below the 20-day SMA of ₹550.01. RSI at 51.5 is neutral — no overbought signal, but no capitulation either. The technical setup is bullish on paper; the ownership flow is not.
Collections truly robust: current book +61 bps, 30+ down, efficiency 97.9%; asset quality de-risked
Disbursement ₹1,496 Cr is historic high; franchise earning customer trust
Credit cost trending toward 1.7% target; NPA trajectory benign
PAT growth only 1.9% YoY despite operational wins; opex inflation structural
AUM growth 4% QoQ vs 20% FY27 guidance; 400 bps gap not addressed or revised
ROA 8.11% misses 8.25–8.5% guidance floor; no leverage boost yet (pushed to FY28)
FII trimming (−4.47 pp) into recovery narrative; institutional skepticism visible
New product 3–6 month window is vague; no detail on type, capital, or contribution
Risks, ranked by impact on holders
AUM growth execution shortfall — 4% QoQ Q1 pace implies 16% annualized, 400 bps below 20% target
HighGuidance credibility is on the line. If 20% is missed and guidance is revised down, stock could re-test 52-week lows. Repayment normalization is not assured.
ROA guidance miss persists in FY27 — opex at 6% vs historical 5% offsets credit cost gains
MediumTwo straight quarters of ROA slippage (8.11% vs 8.25–8.5%) signals cost structure is not cooperating. If FY28 leverage doesn't materialize, valuation re-rating could be steep.
Borrowing cost spike if RBI hikes repo; incremental cost guidance 8.5% fragile if rates rise further
MediumCost of funds already tracking highest in 3 years (8.80% Q1). Even a 25–50 bps rate hike would break the spread guidance and compress NIM further.
Macro headwinds (energy cost inflation, liquidity tightness) could reaccelerate slippages despite Q1 strength
MediumManagement cited energy cost as a forward headwind; repayment rate normalizing from current 30% to guidance 27–28% assumes stable cash flows. A macro deterioration could reverse collections gains.
Yield compression continues (22.5% → 22.25% steady-state); another 10–15 bps over next 2 qtrs expected
LowBulk of repricing done. Further compression is gradual and offset by volume growth and cost of funds improvement. A known headwind, not a surprise.
New product launch timing and contribution uncertain (3–6 month window, no details disclosed)
LowManagement said it will add incrementally to 20% AUM guidance, not be part of it. If launch slips or demand is soft, it becomes a non-event. Asymmetric risk but not a major driver.
What to watch next quarter
1 · AUM growth acceleration — does Q2 show >5% QoQ to stay on track for 20% FY27?
Q1 at 4% QoQ is the red zone. Q2 needs to show a step up to ₹14,300+ Cr (implying 4–4.5% growth minimum) to keep the 20% guidance credible. Disbursements matter less than net AUM expansion; management has proven it can disburse, but repayments are the constraint.
2 · Credit cost trajectory — does Q2 drop below 1.85% toward 1.7%?
Collections are improving, but the company needs to show consistent monthly progress on slippages and write-offs. Q2 credit cost sub-1.8% would validate the 1.7% FY27 guidance and support margin recovery in H2.
3 · Opex ratio stabilization — does FY27 guidance of 5.75–6% look achievable or does Q2 opex ratio stay above 6%?
This is the near-term profit growth constraint. If opex normalizes in Q2 (say, 5.8–5.9% range) as the company laps high employee cost comparisons, PAT growth should accelerate. If opex stays elevated, FY27 PAT guidance could be at risk.
How to think about Five-Star from here
Five-Star's Q1 result is a classic operational recovery masking near-term earnings pressure. The company is genuinely improving its credit profile (collections up, credit cost down) and has reset disbursement run-rates higher. But profit growth is weak (1.9% YoY) because opex inflation is structural and won't reverse until FY28. The 20% AUM growth guidance is not supported by a 4% QoQ Q1 pace and represents meaningful execution risk.
This is a Hold, not a Buy and not a Sell. For holders, the next quarter will clarify whether the 20% AUM guidance is real or aspiration. For new money, the risk-reward is balanced: the operational recovery is genuine, but the growth guidance is not yet proven. The stock's near-term catalyst is not earnings surprise but guidance credibility. The number to track from here is Q2 AUM growth — if it accelerates to 5%+ QoQ, the bull case stands; if it stays flat or slows, expect a guidance revision and a price reset toward ₹450–470 on disappointment.
Five-Star Q1 PAT flat at ₹271 Cr, up 2% YoY; NPM slips to 32.4% as credit costs climb
PAT +1.91% YoY · revenue +5.38% · margins compressing
₹828.98 Cr
+5.38% YoY
₹271.41 Cr
+1.91% YoY
32.36%
-1.3pp YoY
₹9.19
Five-Star Business Finance opened FY27 with a muted quarter. Standalone PAT of ₹271.4 Cr grew just 1.9% YoY over Q1 FY26's ₹266.3 Cr and was near-flat sequentially (+0.8% vs Q4 FY26's ₹269.3 Cr), while total income of ₹838.7 Cr rose 5.4% YoY. The figures are unaudited and standalone (the company has no subsidiaries), carrying an unmodified limited-review opinion from Deloitte Haskins & Sells.
Q1 FY-2027 vs prior quarters
The bottom-line stall sits on rising credit costs: impairment on financial instruments jumped ~29% YoY to ₹61.8 Cr, far outpacing the 5.6% growth in interest income (₹807.6 Cr). Net profit margin slipped to 32.36% from 33.66% a year ago (Q4 FY26: 32.6%), a ~130 bps YoY compression. Asset quality softened at the margin — Gross Stage 3 assets rose to 3.46% from 3.37% at March-end and net Stage 3 to 2.10% from 2.00%. Finance costs were broadly flat YoY at ₹171.5 Cr, so the squeeze is a provisioning story, not a funding one.
The stock went into the print at ₹535.2, up 7.2% over the past month of trading.
What the summary numbers don't show
PBT ₹361.95 Cr (+2.0% YoY) — EPS ₹9.19 vs ₹9.04 YoY; effective tax ~25%.
Balance sheet strong — CRAR 51.25%, D/E 1.03x, net worth ₹7,653 Cr, LCR 296%.
Management is guiding for a return to robust growth with AUM expected to increase by approximately 20% in FY27, driven by a renewed focus on disbursements. They anticipate credit costs for FY27 to be between 1.7% to 1.75% of average AUM, improving to a steady-state level of 1.5% to 1.6% thereafter. The company expects
The print sits well below the company's own trajectory. On the Q4 FY26 call management guided for ~20% AUM growth in FY27, steady ROA of 8.25–8.5% and credit costs of 1.7–1.75%; a 5.4% YoY topline and ~2% PAT growth is a slow start against that ambition, and the uptick in Stage 3 assets bears watching against the credit-cost guide. Street quarterly consensus is thin — Trendlyne's 9-analyst pool pegs FY27 profit growth near ~10%, a pace this Q1 already trails. No management press release accompanied the numbers filing. Capital remains ample (CRAR 51.25%, D/E 1.03x, net worth ₹7,653 Cr).
W1
Credit-cost trajectory: impairment +29% YoY and Gross Stage 3 up to 3.46% — verify against management's FY27 guide of 1.7–1.75%.
W2
AUM/disbursement growth: 5.4% YoY revenue is a slow start versus the ~20% FY27 AUM growth guidance.
W3
Net margin: whether the 32.4% NPM stabilizes or compresses further as provisioning stays elevated.
Clean digital PDF, in INR lakhs (÷100 → ₹Cr). Standalone only — no subsidiary (Note 8). No exceptional items either period, so raw YoY = adjusted YoY. PAT ₹271.41 Cr is profit for period pre-OCI; totalIncome=revOps+otherIncome and PBT−tax check exactly. NPM 32.36% matches Reg 52(4) disclosure. Effective tax rate ~25%.
Recovery firming, but growth pace falls short of 20% AUM target
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Maintained prior guidance on AUM (20%), credit costs (1.7–1.9%), and ROA (8.25–8.5%); delivered on collections and disbursement promises; but AUM pace and ROA both lag guidance, signaling execution risk.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Genuine asset quality turnaround (collections 97.9%, slippages flat, credit cost 1.85%) and record disbursements (₹1,496 Cr) validate the business recovery. However, delivered YoY growth is weak (revenue 5.4%, PAT 1.9%) and AUM expansion at 4% QoQ trails the 20% FY27 guidance target. ROA at 8.11% also misses the 8.25–8.5% ceiling. Hold on near-term softness; upgrade if growth accelerates above 5% YoY.
₹829 Cr
Revenue · +5.4% YoY₹271.4 Cr
Reported PAT · +1.9% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Strong momentum, historical best disbursements ₹1,496 Cr
OVERSTATEDRevenue +5.4% YoY, PAT +1.9% YoY; disbursements strong but AUM only +4% QoQ
20% AUM growth FY27 very comfortably achievable
OVERSTATEDQ1 pace ₹13,722 Cr AUM, +4% QoQ = ~16% annualized if sustained
ROA 8.25–8.5% target
MISSQ1 ROA 8.11%, below guidance floor
Credit cost 1.7–1.9% FY27 trend toward 1.7%
METQ1 credit cost 1.85% at high end of revised range
Collections robust, no asset quality stress in market
METCollection efficiency 97.9%, current book 83.3%, 30+ book 12.38%; trends improving QoQ
Earnings quality
What changed since the last call
Collections significantly improved
UpgradeCurrent book 83.3% (up 0.61 ppts QoQ), 30+ book 12.38% (down 0.31 ppts); collection efficiency 97.9% despite Q1 seasonal weakness
Disbursement run-rate reset higher
UpgradeQ1 ₹1,496 Cr (+23% QoQ, +16% YoY); June at ₹670 Cr suggests ₹600–650 Cr normalized monthly run, up from ₹400s pre-crisis
AUM growth lagging guidance
Downgrade4% QoQ vs 20% FY27 target; high disbursements not converting to AUM growth due to repayments still elevated
ROA below guidance
Downgrade8.11% Q1 vs 8.25–8.5% FY27 target; opex at 6% (up from ~5% historically), NIM flat
Operating leverage pushed to FY28
NeutralOpex +20–21% YoY (employee costs up); steady-state 5.25–5.5% opex ratio not expected until FY28
The Q&A
Analysts pressed hard on AUM growth (Abhijit Tibrewal, Raghav Garg), asset quality stress (Viral Shah, Kunal Shah), and leverage timing (Divyansh Gupta). Management held firm on no credit filter changes, collection momentum intact, and 20% growth achievable—but struggled to reconcile 4% QoQ pace with full-year target. On yields and cost of funds, took defensive stance on October 2024 rate cut (blamed borrowing cost, not regulator).
Operating expense ratio — Renish, ICICI
AnsweredFY27 opex will stay 5.75–6%, no leverage. FY28 onwards leverage kicks in; steady-state 5.25–5.5%.
Yield compression duration — Renish, ICICI
AnsweredYes, bulk done. Yield at 22.5%, likely settle at 22.25%. Another 10–15 bps over next 2 qtrs.
NPA flow-through timing — Viral Shah, IIFL
AnsweredSlippages trending down starting Q2. Recoveries up to ₹35 Cr. No ARC sales. NPAs will trend down.
Asset quality stress market-wide — Viral Shah, IIFL
PartialCollections trends up 7–8 months. Cash flows intact. Watch energy costs, regulator liquidity call.
Normalized slippage number — Abhijit Tibrewal, Motilal Oswal
DodgedComing quarters slippages will trend down. Will guide on steady-state after 1–2 qtrs of data.
Disbursement growth drivers — Abhijit Tibrewal, Motilal Oswal
AnsweredBusiness/collections split freed up business teams. No demand shortage. Productivity gains. Current indicators strong logins, sanction-to-MOD conversion.
Cost of borrowings outlook — Abhijit Tibrewal, Motilal Oswal
AnsweredIncremental ~8.5% (vs current 8.33%). 20–30 bps compression likely if no repo hike. ADB ECB adds hedging costs.
Customer overleveraging risk — Chandrasekhar Sridhar, Fidelity
PartialGold price corrections happening. Overlap with MFI down from 20–21% to 16–17%. Cash flows adequate even if not improving.
Ticket size strategy — Chandrasekhar Sridhar, Fidelity
AnsweredTarget mix: 25% ₹5L. Getting reflected in portfolio. Current average ~₹5L.
Repayment rate increase — Raghav Garg, Ambit Capital
AnsweredCollections stronger so repayments higher. Policy change: best customers no longer asked to prepay existing loan before top-up. Should trend to 27–28% from current 30%.
Write-off trend — Rajiv Mehta, Yes Securities
AnsweredFY27 guidance ₹225–250 Cr (₹60 Cr Q1 run rate). Technical write-offs for tax/GNPA positioning. Will stabilize once softer bucket trends hold.
Credit cost guidance and Stage 1/2 buildup — Rajiv Mehta, Yes Securities
AnsweredMaintain overall coverage 1.75–1.8%; mix of Stage 1/2 and Stage 3 adjustments per portfolio composition. FY28 credit cost ~1.6–1.7%.
Current/30+ book settling point — Kunal Shah, Citigroup
AnsweredThumb rule: Stage 1 ~91%, Stage 2 ~6–7%, Stage 3 ~2.5% (steady-state NPA sub-3%). Current ~87–88%, 1–30 ~3–4%, 31–60/61–90 ~3–3.5% each.
Operating leverage timing — Kunal Shah, Citigroup
AnsweredYes. No ESOP. Salary realignment, incentive structure. Operating leverage from FY28. Normal 50–60 branch additions FY27.
Borrowing cost vs leverage ambition — Divyansh Gupta, Latent PMS
AnsweredIncremental cost expected ~8.5%, not current 8.33%. Adequate lines available. Took ₹450 Cr this qtr; holding ₹1,850 Cr liquidity.
Debt-to-equity 2x timing — Divyansh Gupta, Latent PMS
AnsweredMedium-term, 6–8 quarters. Depends on growth trajectory and new product diversification. Adding ₹1,100–1,200 Cr PAT annually offsets leverage build.
New product scope — Divyansh Gupta, Latent PMS
PartialHousing already launched but not prioritized. New product apart from that. Will announce in 3–6 months. Addition to 20% AUM growth, not included.
Incremental disbursement ticket size — Chirag Fialoke, MS Capital
AnsweredAverage ticket ₹4.5–5L this quarter, will stay there. Intent not to add smaller customers but right quality at ₹5L avg.
Confidence in 20% AUM growth — Kunal Thanvi, Banyan Tree
PartialAssuming ₹1,500 Cr Q1 run rate + 10% for seasonal Q3–Q4, implies ₹6,500–6,800 Cr annual; comfortably hits 20% growth.
Business/collections split cultural impact — Kunal Thanvi, Banyan Tree
AnsweredNo cultural shift. Business teams still responsible for current account collections. Incentives dependent on collection % and growth. Only arrears moved to collections team.
ROE target — Darshan Deora, Indvest Group
AnsweredCurrent 8% ROA on AUM. Steady-state ROA target 6–6.5%. At 3x leverage, ROE 18–20%.
Yield reset in October 2024 — Darshan Deora, Indvest Group
AnsweredBorrowing cost relief (11%+ → 9%+). Board decision to pass 200 bps to customers. Not regulatory-driven. Lending rates will track borrowing cost.
June disbursement run-rate — Renish, ICICI
AnsweredJune ₹670 Cr. Average ₹600–670 Cr monthly should be new normal for rest of year.
Guidance
AUM growth ~20% FY27
MediumQ1 pace 4% QoQ implies ~16% annualized; management says 'very comfortably' achievable with ₹1,500 Cr disbursement run-rate + 10% seasonal boost
Credit cost 1.7–1.9% FY27 (revised from 1.7–1.75%)
HighQ1 at 1.85%; management expects trend toward 1.7% given improving collections, slippage stabilization
ROA 8.25–8.5% FY27
LowQ1 delivered 8.11%, below floor; opex at 6% this year offsets credit cost gains; ROA pressure until FY28 leverage kicks in
Branch expansion 50–60 per quarter FY27
HighQ1 added 12 branches (mostly Maharashtra), normal run-rate. No abnormal capex beyond branch infrastructure expected.
Risks the call surfaced
AUM growth execution
High4% QoQ AUM pace in Q1 implies 16% annualized, 400 bps below 20% FY27 guidance. Repayments still elevated as collection efficiencies normalize. Unlikely to hit target without material acceleration.
ROA guidance
MediumQ1 ROA 8.11% fell below 8.25–8.5% guidance floor. Opex at 6% (vs 5% historically) due to employee cost inflation. Even with credit cost improvements, NIM flat limits ROA recovery.
Interest rate / borrowing cost
MediumManagement guiding for 8.5% incremental borrowing cost; if RBI raises repo, cost could exceed guidance. ADB ECB tranche adds hedging costs. Spread compression risk if rate hike occurs.
Asset quality normalization risk
MediumCollections currently strong (97.9%, current book 83.3%) but Q1 is seasonally soft. Energy cost inflation and potential liquidity tightness (regulator price hike) cited as headwinds. If customer cash flows deteriorate, slippages could reaccelerate.
Yield compression
LowYield at 22.5%, management expects ~22.25% steady-state. Likely another 10–15 bps compression over next 2 quarters. Lending rate dropped 200 bps October 2024 to track borrowing cost.
Management
Score 8/10. Clear and detailed on metrics; addressed 20+ distinct questions with specificity (e.g., opex 5.75–6% FY27, credit cost 1.85% with 1.7% target). Some deflection on precise data (referred to IR team on 60–90 bucket %, overall collection efficiency). Honest about October 2024 yield cut rationale (borrowing cost, not regulator). Strong execution on collections turnaround (current book +0.61 ppts QoQ, 30+ down 0.31 ppts). Disbursement scaling real (₹1,496 Cr +23% QoQ). Missed ROA guidance (8.11% vs 8.25–8.5%). AUM growth lagging 20% target at 4% QoQ pace. Opex inflation (20–21% YoY) pushed operating leverage to FY28.
1 · Q2 FY27
Slippages trend downward, credit cost move below 1.85%
2 · H2 FY27
New product launch (housing or adjacent), diversify revenue
3 · FY28 onwards
Operating leverage kicks in, opex ratio 5.25–5.5%, ROE expansion
Hold on near-term softness; upgrade if growth accelerates above 5% YoY.